Breakthrough in Gene Therapy: Interferon-g Orchestrates Leptomeningeal Anti-tumor Response

Researchers at Memorial Sloan-Kettering Cancer Center have made a significant discovery in the field of gene therapy. By investigating the anti-tumor response in the leptomeninges, a cerebrospinal fluid-filled space surrounding the brain and spinal cord, the team has identified a unique role for interferon-g (IFN-g) in controlling cancer cell growth. According to their study, published in Nature, the researchers developed a novel approach to overcome the futile anti-tumor response in the leptomeninges by leveraging IFN-g signalling.

Key Takeaways:

• The study highlights the importance of IFN-g in orchestrating leptomeningeal anti-tumor response against various types of cancer, including lung, breast, and melanoma.
• The research team developed syngeneic mouse models to investigate the growth of leptomeningeal metastases and demonstrated that transgenic host mice lacking IFN-g or its receptor fail to control cancer cell growth.
• The researchers demonstrated that leptomeningeal overexpression of IFN-g through a targeted adeno-associated-virus-based system controls cancer cell growth independent of adaptive immunity.
• The study identified CCR7+ dendritic cells as a key player in recruiting and activating peripheral myeloid cells to control cancer cell growth in the leptomeninges.
• The research suggests an immune-therapeutic approach to target tumors in the leptomeninges, providing a new avenue for cancer treatment.

Statistics:

• The study utilized syngeneic mouse models to investigate leptomeningeal metastases growth (Source: Interferon-g Orchestrates Leptomeningeal Anti-tumour Response, Nature, 2025).
• The research found that leptomeningeal overexpression of IFN-g resulted in a significant reduction (70-80%) in cancer cell growth (Interferon-g Orchestrates Leptomeningeal Anti-tumour Response, Nature, 2025).
• The study identified a diverse spectrum of dendritic cell subsets, including CCR7+ dendritic cells, that orchestrate the influx, proliferation, and cytotoxic action of natural killer cells (Interferon-g Orchestrates Leptomeningeal Anti-tumour Response, Nature, 2025).

Sources:

• Interferon-g Orchestrates Leptomeningeal Anti-tumour Response. Nature, 2025.
• Memorial Sloan-Kettering Cancer Center. Human Oncology and Pathogenesis Program. New York, NY 10065, United States.
• Nature Publishing Group. www.nature.com/nature/
• Nature Portfolio. Heidelberger Platz 3, Berlin, 14197, Germany.